AxoGen, Inc. (AXGN)
USD 16.14
(-5.28%)
USD 16.14
(-5.28%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 46.6 Million USD | -29.51% |
| 2022 | 66.11 Million USD | 0.76% |
| 2021 | 65.61 Million USD | 24.04% |
| 2020 | 52.9 Million USD | 3216.68% |
| 2019 | 1.59 Million USD | 4457.14% |
| 2018 | 35 Thousand USD | -99.82% |
| 2017 | 19.9 Million USD | -1.78% |
| 2016 | 20.26 Million USD | -20.67% |
| 2015 | 25.54 Million USD | 1.84% |
| 2014 | 25.08 Million USD | -1.1% |
| 2013 | 25.36 Million USD | 17.53% |
| 2012 | 21.58 Million USD | 390.04% |
| 2011 | 4.4 Million USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | -100.0% |
| 2003 | 62.43 Thousand USD | 479.74% |
| 2002 | 10.77 Thousand USD | -91.4% |
| 2001 | 125.17 Thousand USD | 301.39% |
| 2000 | 31.18 Thousand USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| 1994 | - USD | 0.0% |
| 1993 | - USD | 0.0% |
| 1992 | - USD | 0.0% |
| 1991 | - USD | -100.0% |
| 1990 | 800 Thousand USD | -33.33% |
| 1989 | 1.2 Million USD | 200.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 47.04 Million USD | 0.47% |
| 2024 Q1 | 46.82 Million USD | 0.48% |
| 2023 Q1 | 66.02 Million USD | -0.15% |
| 2023 Q4 | 46.6 Million USD | -29.71% |
| 2023 Q3 | 66.3 Million USD | 0.03% |
| 2023 FY | 46.6 Million USD | -29.51% |
| 2023 Q2 | 66.28 Million USD | 0.4% |
| 2022 FY | 66.11 Million USD | 0.76% |
| 2022 Q1 | 65.91 Million USD | 0.46% |
| 2022 Q4 | 66.11 Million USD | -0.01% |
| 2022 Q3 | 66.12 Million USD | 0.31% |
| 2022 Q2 | 65.91 Million USD | -0.0% |
| 2021 Q2 | 66.42 Million USD | 25.64% |
| 2021 Q4 | 65.61 Million USD | -2.8% |
| 2021 FY | 65.61 Million USD | 24.04% |
| 2021 Q1 | 52.87 Million USD | -0.06% |
| 2021 Q3 | 67.5 Million USD | 1.63% |
| 2020 FY | 52.9 Million USD | 3216.68% |
| 2020 Q1 | 1.18 Million USD | -25.45% |
| 2020 Q2 | 31.96 Million USD | 2587.97% |
| 2020 Q3 | 50.79 Million USD | 58.93% |
| 2020 Q4 | 52.9 Million USD | 4.15% |
| 2019 Q1 | 3.22 Million USD | 9108.57% |
| 2019 Q2 | 2.38 Million USD | -26.12% |
| 2019 Q3 | 2 Million USD | -15.92% |
| 2019 Q4 | 1.59 Million USD | -20.33% |
| 2019 FY | 1.59 Million USD | 4457.14% |
| 2018 Q4 | 35 Thousand USD | -8.65% |
| 2018 Q3 | 38.31 Thousand USD | -15.31% |
| 2018 Q2 | 45.24 Thousand USD | -99.75% |
| 2018 Q1 | 17.76 Million USD | -10.77% |
| 2018 FY | 35 Thousand USD | -99.82% |
| 2017 Q3 | 20.35 Million USD | 0.21% |
| 2017 FY | 19.9 Million USD | -1.78% |
| 2017 Q4 | 19.9 Million USD | -2.22% |
| 2017 Q2 | 20.31 Million USD | 0.19% |
| 2017 Q1 | 20.27 Million USD | 0.05% |
| 2016 Q3 | 24.99 Million USD | 0.18% |
| 2016 Q1 | 24.8 Million USD | -2.91% |
| 2016 FY | 20.26 Million USD | -20.67% |
| 2016 Q4 | 20.26 Million USD | -18.92% |
| 2016 Q2 | 24.95 Million USD | 0.6% |
| 2015 Q3 | 25.53 Million USD | 0.44% |
| 2015 Q2 | 25.42 Million USD | 0.62% |
| 2015 Q1 | 25.26 Million USD | 0.73% |
| 2015 FY | 25.54 Million USD | 1.84% |
| 2015 Q4 | 25.54 Million USD | 0.04% |
| 2014 FY | 25.08 Million USD | -1.1% |
| 2014 Q3 | 28.17 Million USD | 3.42% |
| 2014 Q2 | 27.24 Million USD | 3.76% |
| 2014 Q1 | 26.25 Million USD | 3.52% |
| 2014 Q4 | 25.08 Million USD | -10.96% |
| 2013 Q4 | 25.36 Million USD | 4.24% |
| 2013 Q3 | 24.33 Million USD | 4.06% |
| 2013 Q2 | 23.38 Million USD | 4.21% |
| 2013 Q1 | 22.43 Million USD | 3.98% |
| 2013 FY | 25.36 Million USD | 17.53% |
| 2012 FY | 21.58 Million USD | 390.04% |
| 2012 Q4 | 21.58 Million USD | 355.35% |
| 2012 Q3 | 4.73 Million USD | 36.94% |
| 2012 Q2 | 3.46 Million USD | -11.99% |
| 2012 Q1 | 3.93 Million USD | -10.71% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | 4.82 Million USD | 0.0% |
| 2011 Q4 | 4.4 Million USD | -8.75% |
| 2011 FY | 4.4 Million USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2004 Q2 | 57.98 Thousand USD | -4.07% |
| 2004 FY | - USD | -100.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | -100.0% |
| 2004 Q1 | 60.44 Thousand USD | -3.2% |
| 2003 FY | 62.43 Thousand USD | 479.74% |
| 2003 Q4 | 62.43 Thousand USD | -5.15% |
| 2003 Q1 | 8727.00 USD | -18.97% |
| 2003 Q2 | 6612.00 USD | -24.24% |
| 2003 Q3 | 65.82 Thousand USD | 895.54% |
| 2002 Q1 | 93.8 Thousand USD | 0.0% |
| 2002 Q2 | 284 Thousand USD | 202.76% |
| 2002 Q3 | 257.5 Thousand USD | -9.33% |
| 2002 Q4 | 10.77 Thousand USD | -95.82% |
| 2002 FY | 10.77 Thousand USD | -91.4% |
| 2001 Q2 | 859.62 Thousand USD | 2.99% |
| 2001 Q3 | 851 Thousand USD | -1.0% |
| 2001 FY | 125.17 Thousand USD | 301.39% |
| 2001 Q1 | 834.63 Thousand USD | -0.49% |
| 2000 Q4 | 838.71 Thousand USD | 3247.51% |
| 2000 Q3 | 25.05 Thousand USD | -19.65% |
| 2000 Q2 | 31.18 Thousand USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 FY | 31.18 Thousand USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| 1995 Q2 | - USD | 0.0% |
| 1995 Q4 | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1994 Q4 | - USD | 0.0% |
| 1993 Q4 | - USD | 0.0% |
| 1993 Q2 | - USD | 0.0% |
| 1993 Q1 | - USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1992 FY | - USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1992 Q4 | - USD | 0.0% |
| 1992 Q1 | - USD | 0.0% |
| 1992 Q3 | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1991 FY | - USD | -100.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 Q2 | - USD | -100.0% |
| 1991 Q1 | 700 Thousand USD | 0.0% |
| 1990 Q2 | 800 Thousand USD | -46.67% |
| 1990 Q1 | 1.5 Million USD | 0.0% |
| 1990 FY | 800 Thousand USD | -33.33% |
| 1990 Q4 | 700 Thousand USD | 0.0% |
| 1990 Q3 | 700 Thousand USD | -12.5% |
| 1989 Q3 | 1 Million USD | -16.67% |
| 1989 FY | 1.2 Million USD | 200.0% |
| 1989 Q2 | 1.2 Million USD | 0.0% |
| 1989 Q4 | 1.5 Million USD | 50.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | -29.087% |
| BrainsWay Ltd. | 239 Thousand USD | -19399.163% |
| Cerus Corporation | 59.79 Million USD | 22.063% |
| Envoy Medical, Inc. | 404 Thousand USD | -11435.396% |
| electroCore, Inc. | 537 Thousand USD | -8578.399% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -388258.333% |
| IceCure Medical Ltd | 376 Thousand USD | -12294.415% |
| Inogen, Inc. | 18.27 Million USD | -155.079% |
| OrthoPediatrics Corp. | 13.45 Million USD | -246.259% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -23318.593% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -12712.737% |
| MaxCyte, Inc. | 17.96 Million USD | -159.352% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -84197.446% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | 49.947% |
| PAVmed Inc | 2.96 Million USD | -1474.426% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | -649.968% |
| RxSight, Inc. | 1.21 Million USD | -3748.307% |
| Sight Sciences, Inc. | 31.7 Million USD | -46.976% |
| SI-BONE, Inc. | 36.06 Million USD | -29.219% |
| TELA Bio, Inc. | 40.51 Million USD | -15.027% |
| Treace Medical Concepts, Inc. | 53 Million USD | 12.083% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | -2963.971% |
| Acutus Medical, Inc. | 32.65 Million USD | -42.718% |
| Talis Biomedical Corporation | 16.78 Million USD | -177.63% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | -1052.114% |
| CVRx, Inc. | 30.38 Million USD | -53.39% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | -4482.715% |
| Bioventus Inc. | 366.99 Million USD | 87.302% |
| Venus Concept Inc. | 70.79 Million USD | 34.167% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | -3646.222% |
| LivaNova PLC | 568.54 Million USD | 91.803% |
| 908 Devices Inc. | 3.92 Million USD | -1086.129% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 90.881% |
| Nemaura Medical Inc. | 3.08 Million USD | -1409.335% |
| NeuroPace, Inc. | 56.95 Million USD | 18.174% |
| LENSAR, Inc. | 1.75 Million USD | -2563.029% |
| Apyx Medical Corporation | 33.18 Million USD | -40.434% |
| Cutera, Inc. | 418.69 Million USD | 88.869% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | -209.778% |
| BioSig Technologies, Inc. | 103 Thousand USD | -45145.631% |
| Anika Therapeutics, Inc. | 26.9 Million USD | -73.22% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | -368.419% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 96.862% |
| Axonics, Inc. | 25.84 Million USD | -80.352% |
| Outset Medical, Inc. | 134.59 Million USD | 65.375% |
| IRIDEX Corporation | 1.75 Million USD | -2561.508% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 9.225% |
| IRadimed Corporation | 1.61 Million USD | -2785.492% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -26378.977% |
| INVO Bioscience, Inc. | 6.77 Million USD | -587.757% |
| Telesis Bio, Inc. | 5.26 Million USD | -784.475% |
| Viemed Healthcare, Inc. | 5.97 Million USD | -680.451% |
| Varex Imaging Corporation | 464.2 Million USD | 89.961% |
| Quipt Home Medical Corp. | 60.82 Million USD | 23.377% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -7825.68% |
| Pulmonx Corporation | 35.08 Million USD | -32.814% |
| Dynatronics Corporation | 3.25 Million USD | -1330.208% |
| Modular Medical, Inc. | 817 Thousand USD | -5604.162% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -30762.914% |
| Semler Scientific, Inc. | 70 Thousand USD | -66475.714% |
| InMode Ltd. | 6.61 Million USD | -604.718% |
| Bruker Corporation | 1.14 Billion USD | 95.928% |
| Cytosorbents Corporation | 2.54 Million USD | -1732.702% |
| DexCom, Inc. | 2.57 Billion USD | 98.189% |
| Align Technology, Inc. | 96.96 Million USD | 51.94% |
| Viveve Medical, Inc. | 5.12 Million USD | -809.504% |
| ZimVie Inc. | 508.79 Million USD | 90.841% |
| Movano Inc. | 15.00 USD | -310686566.667% |
| Cytek Biosciences, Inc. | 18.12 Million USD | -157.12% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 88.309% |
| Profound Medical Corp. | 4.97 Million USD | -836.853% |
| Insulet Corporation | 1.36 Billion USD | 96.589% |
| enVVeno Medical Corporation | 1.06 Million USD | -4279.981% |
| Surmodics, Inc. | 29.4 Million USD | -58.487% |
| iCAD, Inc. | 273 Thousand USD | -16970.696% |
| Nuwellis, Inc. | 221 Thousand USD | -20987.33% |
| Biotricity, Inc. | 10.85 Million USD | -329.29% |
| iRhythm Technologies, Inc. | 34.95 Million USD | -33.342% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -7072.44% |
| InspireMD, Inc. | 1.03 Million USD | -4389.692% |
| PAVmed Inc. | 2.96 Million USD | -1474.426% |
| BIOLASE, Inc. | 13.98 Million USD | -233.236% |
| Beyond Air, Inc. | 14.72 Million USD | -216.575% |
| FONAR Corporation | 37.92 Million USD | -22.868% |
| Vivani Medical, Inc. | 19.31 Million USD | -141.304% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | -4.463% |
| Inari Medical, Inc. | 30.35 Million USD | -53.527% |
| UFP Technologies, Inc. | 28 Million USD | -66.439% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -10636.905% |
| Tenon Medical, Inc. | 428 Thousand USD | -10788.551% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -4550.998% |
| Co-Diagnostics, Inc. | 2.15 Million USD | -2065.386% |
| AdaptHealth Corp. | 2.09 Billion USD | 97.775% |
| Sintx Technologies, Inc. | 3.68 Million USD | -1163.982% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | -25.199% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -7825.68% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -7719.295% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 94.777% |
| TransMedics Group, Inc. | 506.2 Million USD | 90.794% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -7577.595% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -50289.793% |
| Hyperfine, Inc. | 64 Thousand USD | -72717.188% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 75.308% |
| Biomerica, Inc. | 459 Thousand USD | -10053.159% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -10268.134% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -24429.573% |
| Silk Road Medical, Inc | 75.62 Million USD | 38.377% |